We illuminated the genomic landscape of both EBV and host cells from precursor lesions to invasive gastric carcinomas and demonstrated the synergistic activation of the PI3K and Wnt pathways in EBVaGCs, providing a potential new strategy for the clinical management of patients with EBVaGCs. The gene discussed is PIK3CA; the disease is gastric carcinoma.